Fri, September 1, 2023
Thu, August 31, 2023
Wed, August 30, 2023
Tue, August 29, 2023
Mon, August 28, 2023
Sun, August 27, 2023
Fri, August 25, 2023
Thu, August 24, 2023

Rick Bienkowski Reiterated (BEAM) at Buy and Held Target at $56 on, Aug 29th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-56-on-aug-29th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Rick Bienkowski of Cantor Fitzgerald, Reiterated "Beam Therapeutics Inc." (BEAM) at Buy and Held Target at $56 on, Aug 29th, 2023.

Rick has made no other calls on BEAM in the last 4 months.



There are 4 other peers that have a rating on BEAM. Out of the 4 peers that are also analyzing BEAM, 3 agree with Rick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Decreased Target to $35 on, Wednesday, August 9th, 2023
  • Richard Law of "Credit Suisse" Maintained at Hold with Increased Target to $47 on, Wednesday, August 9th, 2023
  • Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $42 on, Thursday, May 11th, 2023


This is the rating of the analyst that currently disagrees with Rick


  • Samantha Semenkow of "Citigroup" Maintained at Strong Buy with Decreased Target to $56 on, Wednesday, August 9th, 2023

Publication Contributing Sources